Timolol
1 NDC across 1 manufacturer|0 Generic,1 Brand
Timolol is used to treat angina pectoris, open-angle glaucoma, heart failure, hypertension and myocardial infarction, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 31, 1995, and the first generic was approved Sep 30, 2016. In 2024, Medicare Part D spent $4 million on Timolol across 14,000 claims for 5,147 beneficiaries.
Timolol is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $31.12 to $31.12 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$31.12 – $31.12
per ML
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing TIMOLOL
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
BETIMOL 0.5% EYE DROPS | $31.1223 per ML | — |
Frequently Asked Questions
What is Timolol used to treat?
Timolol is used to treat angina pectoris, open-angle glaucoma, heart failure, hypertension and myocardial infarction, per the National Library of Medicine's MED-RT classification.
When did Timolol become available as a generic?
FDA approved the first generic Timolol (ANDA) on Sep 30, 2016.
How much does Medicare spend on Timolol?
In 2024, Medicare Part D spent $4 million on Timolol across 14,000 claims for 5,147 beneficiaries.
How many Timolol products are on the market?
The Timolol drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Timolol?
NADAC reference prices for Timolol range from $31.1223 to $31.1223 per ML.
Which manufacturers make Timolol?
1 manufacturer lists Timolol in NADAC. Ranked by number of NDCs, the largest are Thea Pharma Inc. (1).